Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy

NACompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Type 2 Spinal Muscular AtrophyType 3 Spinal Muscular Atrophy
Interventions
OTHER

Strength, function and activity measurements

OTHER

Muscle MRI

OTHER

Electrophysiology measurements

OTHER

Blood sampling for biomarker analysis

Trial Locations (9)

Unknown

Reference centre for neuromuscular diseases - UZ Leuven - Department of Pediatrics - University Hospitals Leuven, Leuven

Centre de Référence neuromusculaire - CHR La Citadelle, Liège

"Service de Rééducation Pédiatrique Infantile L'Escale - Hôpital Femme Mère Enfant", Bron

Maladie Neuromusculaire de l'enfant - Service Maladies infectieuses et neurologie infantile - Hôpital Roger Salengro, Lille

Centre de référence Maladies Neuromusculaires Nantes-Angers - Hôtel Dieu, Nantes

I-Motion Institute - Trousseau Hospital, Paris

Neuropédiatrie - Service de Pédiatrie 1 - CHU Hautepierre, Strasbourg

Unité de neurologie pédiatrique - Hôpital des enfants, Toulouse

Universitätsklinikum Essen (AöR) - Klinik für Kinderheilkunde I - Sozialpädiatrisches Zentrum, Essen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Institut Roche

UNKNOWN

lead

Institut de Myologie, France

OTHER

NCT02391831 - Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy | Biotech Hunter | Biotech Hunter